Pharmacodynamics of the glucagon‐like peptide‐1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin
Author:
Affiliation:
1. Kansai Electric Power Hospital Osaka Japan
2. Sanofi K.K. Tokyo Japan
3. Sanofi Chilly Mazarin France
4. Sanofi Frankfurt Germany
5. University Hospital Sainte‐Marguerite Marseille France
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12276
Reference33 articles.
1. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes
2. Insulin-secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non-obese Japanese patients
3. β-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S.
4. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians
5. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical pharmacokinetics of glipizide: a systematic review;Expert Opinion on Drug Metabolism & Toxicology;2024-09-12
2. Association of Novel Antihyperglycemic Drugs Versus Metformin With a Decrease in Asthma Exacerbations;The Journal of Allergy and Clinical Immunology: In Practice;2024-08
3. Perioperative probiotics attenuates postoperative cognitive dysfunction in elderly patients undergoing hip or knee arthroplasty: A randomized, double-blind, and placebo-controlled trial;Frontiers in Aging Neuroscience;2023-01-05
4. Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL);Advances in Therapy;2022-10-07
5. The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study;Advances in Therapy;2022-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3